Global Wearable Infusion Systems Market Analysis - Trends, Technologies & Opportunities Report - Key Vendors: Roche, SteadyMed, scPharmaceuticals

Dublin, March 11, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/6s2b7d/wearable_infusion) has announced the addition of the "Wearable Infusion Systems" report to their offering.

This industry report examines the wearable infusion systems market and the drivers, challenges and opportunities facing this market. The report considers current and future factors, resulting in an unrivalled understanding of the market and where it's heading.

Wearbale infusion systems distinguish themselves from syringes and injectors by delivering drug volumes in excess of 1-2 mL for durations that are measured in minutes rather than seconds. Several products in this device class have already reached the market, and recent agreements between device suppliers and pharma companies validate the market need that wearable infusion systems address. We expect wearable infusion systems to achieve and sustain double digit unit growth through the end of the decade.

Questions Answered:

• What wearable infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
• What are the therapeutic markets being targeted by wearable infusion systems?
• What are the essential design factors, material selection issues, technologies and market development issues for wearable infusion systems?
• What are the major factors that will drive wearable infusion systems demand?
• How are wearable infusion systems currently aligned with various drug classes and therapeutic markets?
• What is the addressable market for wearable infusion systems?
• What is the expected impact of wearable infusion systems on drug delivery markets?
• Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Companies Mentioned:

• CSL Behring
• Ferring
• Roche
• SteadyMed
• scPharmaceuticals

Report Structure:

1. Executive Summary Injectable/Infusible Market Segment Dynamics Drug Development Trends

2. Volumes and Viscosities

3. Wearable Infusion Systems - Commercial Devices

4. OEM Devices

5. Captive Devices

6. Single Product Devices

7. Wearable Infusions Systems - Near-Term Drug Products

8. Capricor

9. Wearable Infusion Therapeutics - The Addressable Market

10. Inflammatory Autoimmune Diseases

11. Market Factors

12. Self-Administration and Patient Compliance

13. Company Profiles

For more information visit http://www.researchandmarkets.com/research/6s2b7d/wearable_infusion

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Infusions and Injectables